Esther P A H Hoppenreijs

Author

Also Known As

E Hoppenreijs, E P A H Hoppenreijs, E. Hoppenreijs, E. P. A. H. Hoppenreijs, E. Papadopoulou-Alataki, E.P. Hoppenreijs, E.P.A.H. Hoppenreijs, ESTHER P.A.H. HOPPENREIJS, Esther Hoppenreijs, Esther P A H Hoppenreijs

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

Radboud University Nijmegen Radboud University Medical Center Erasmus MC - Sophia Children’s Hospital Emma Kinderziekenhuis University Medical Center Utrecht

About

Esther P A H Hoppenreijs is an author at Radboud University Nijmegen specializing in medicine, autoimmunity, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	117
2	Immunology	2	2	104
3	Pathology	2	2	104
4	Gastroenterology	1	1	50
5	Microbiology	1	1	13

Esther P A H Hoppenreijs

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study Wilco de Jager, Esther P A H Hoppenreijs, Nico Wulffraat, Annals of the Rheumatic Diseases	2006	339
Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national register François Prince, Marinka Twilt, R. ten Cate, Annals of the Rheumatic Diseases	2008	211
High prevalence of methotrexate intolerance in juvenile idiopathic arthritis: Development and validation of a methotrexate intolerance severity score Maja Bulatović, Marloes W Heijstek, Marleen Verkaaik, Arthritis & Rheumatism	2011	176
The Toll-like receptor 4 agonist MRP8/14 protein complex is a sensitive indicator for disease activity and predicts relapses in systemic-onset juvenile idiopathic arthritis Dirk Holzinger, Michael Frosch, Astrid Kastrup, Annals of the Rheumatic Diseases	2012	160
Factors Associated With Treatment Response to Etanercept in Juvenile Idiopathic Arthritis M.H. Otten, Femke H. M. Prince, Wineke Armbrust, JAMA	2011	143
Safety of measles, mumps and rubella vaccination in juvenile idiopathic arthritis M.W. Heijstek, Gecilmara Salviato Pileggi, Evelien Zonneveld‐Huijssoon, Annals of the Rheumatic Diseases	2007	121
Galectin‐9 and CXCL10 as Biomarkers for Disease Activity in Juvenile Dermatomyositis: A Longitudinal Cohort Study and Multicohort Validation Judith Wienke, Felicitas Bellutti Enders, Johan Lim, Arthritis & Rheumatology	2019	87
MRP8/14 serum levels as a predictor of response to starting and stopping anti-TNF treatment in juvenile idiopathic arthritis Janneke Anink, Lisette W. A. van Suijlekom‐Smit, M.H. Otten, Arthritis Research & Therapy ImmunologyPathologyPsoriatic ArthritisInflammationRheumatoid Disorder	2015	77
Disease recurrence in localized scleroderma: a retrospective analysis of 344 patients with paediatric- or adult-onset disease Jorre S. Mertens, Marieke M.B. Seyger, Wietske Kievit, British Journal of Dermatology	2014	75
Tumor Necrosis Factor-blocking Agents for Children with Enthesitis-related Arthritis — Data from the Dutch Arthritis and Biologicals in Children Register, 1999–2010 M.H. Otten, Femke H. M. Prince, Marinka Twilt, The Journal of Rheumatology	2011	72

Page 1